Mokemei Zhengzhou Biotechnology MKM
Retatrutide
Finnrick tested 5 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Mokemei Zhengzhou Biotechnology MKM between 23 Oct 2025 and 23 Apr 2026. Test scores average over 5, no score below 4, and at least 2 tests warrant a tentative Finnrick Rating of C (Okay).
Finnrick Rating™
Tentative Rating
Mokemei Zhengzhou Biotechnology MKM
Retatrutide
Tested 5 Samples
Last test 23 Apr 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Mokemei Zhengzhou Biotechnology MKM
Samples are tested in commercial labs
Tests Count
5
Scores
AVGMINMAX
Last
23 Apr 2026
First
23 Oct 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 23 Apr 2026 | View | 15mg | 14.9mg | -0.7% | 99.90% | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 23 Apr 2026 | View | 15mg | 16mg | +6.7% | 99.90% | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 19 Mar 2026 | View | 10mg | 12.5mg | +25.0% | 99.90% | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 17 Nov 2025 | View | 40mg | 39.4mg | -1.5% | 99.67% | PT40 | No Label / Silver Crimp / Red Cap | Lab E | Public | |
| 23 Oct 2025 | View | 5mg | 4.12mg | -17.6% | 99.95% | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab E | Public | |